Molecular BrainNeurosciencePeer-reviewed journal article
Surface GluA1 and glutamate transmission are increased in VPS35 D620N neurons and altered by LRRK2 kinase inhibition
Chelsie KadgieniD, Anusha KameshiD, Jaskaran Khinda, Li Ping Cao, Jesse Fox, Matthew James FarreriD, Austen J. MilnerwoodiD
Abstract
Vacuolar protein sorting 35 (VPS35) regulates receptor recycling from endosomes. A missense mutation in VPS35 (D620N) leads to autosomal-dominant, late-onset Parkinsons disease. Here, we use a VPS35 D620N knock-in mouse to study the neurobiology of this mutation. In brain tissue, we confirm previous findings that the mutation results in reduced binding of VPS35 with WASH-complex member FAM21, and robustly elevated phosphorylation of the LRRK2 kinase substrate Rab10. In cultured cortical neurons, the mutation results in increased endosomal recycling protein density (VPS35-FAM21 co-clusters and Rab11 clusters), glutamate release, and GluA1 surface expression. LRRK2 kinase inhibition exerted genotype-specific effects on GluA1 surface expression, but did not impact glutamate release phenotypes. These results improve our understanding of the early effects of the D620N mutation on cellular functions that are specific to neurons. These observations provide candidate pathophysiological pathways that may drive eventual transition to late-stage parkinsonism in VPS35 families, and support a synaptopathy model of neurodegeneration.
- Citations
- 19
- FWCI
- 1.31
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition
Anusha Kamesh, Chelsie Kadgien, … Austen J. Milnerwood·npj Parkinson s DiseasePeer-reviewed·May 3, 2025
- The Parkinson's Disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress
K. R. McCarron, H. Elcocks, … M. J. Clague·bioRxiv·Dec 2, 2023
- Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine dynamics in VPS35 p.D620N knock-in mice
Mengfei Bu, Jordan Follett, … Matthew James Farrer·bioRxiv·May 14, 2023
- Parkinsons VPS35 mutation induces LRRK2 mediated lysosomal association of RILPL1 and TMEM55B
Prosenjit Pal, Matthew Taylor, … Dario R. Alessi·Science AdvancesPeer-reviewed·Dec 13, 2023
- Vps35 p.D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation and inflammation
Isaac Bul Deng, Mengfei Bu, … Matthew James Farrer·bioRxiv·Sep 3, 2026
- Parkinson's disease-linked D620N mutation selectively alters the brain-specific protein interactome of VPS35
Erin T. Williams, Maxwell A. Frye, … Darren J. Moore·Neurobiology of DiseasePeer-reviewed·Sep 1, 2026